TD Asset Management »

Corbus Pharmaceuticals Hldgs shares owned by TD Asset Management

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $832k 21k 39.24

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Canadian Pacific Kansas City (CP)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Meta Platforms Cl A (META)
Canadian Natl Ry (CNI)
Amazon (AMZN)
Enbridge (ENB)
Visa Com Cl A (V)
Broadcom (AVGO)

View all positions for TD Asset Management

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Point72 Asset Management
Ikarian Capital
Vanguard Group
Adage Capital Partners GP
Octagon Capital Advisors
Citadel Advisors
Henderson Group
Millennium Management
Assenagon Asset Management
BlackRock
T. Rowe Price Associates
Barclays
Morgan Stanley
Boothbay Fund Management

View all funds holding Corbus Pharmaceuticals Hldgs